Lipoprotein(a) was significantly reduced in patients treated with evolocumab, and those with the highest levels at baseline had the greatest benefit from this PCSK9 inhibitor, according to data ...
Trulicity helps lower blood sugar in adults and children ages 10 years and older with type 2 diabetes. It also may reduce major heart risks in adults with type 2 diabetes who have or are at risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback